Henry Nordhoff

Henry Nordhoff

Chief Executive Officer at
Banyan Biomarkers, Inc.
84 year
Health Technology
Consumer Services
Health Services

Profile

Henry L.
Nordhoff
is currently the Chairman & Chief Executive Officer at Banyan Biomarkers, Inc. He is also the Chairman at Chugai Pharma USA LLC, Chairman at Proactive Diagnostics, and a Trustee at Sanford Burnham Prebys Medical Discovery Institute.
Previously, he was the President & Chief Executive Officer at Targetech, Inc. and the Non-Executive Chairman at Gen-Probe, Inc. He also served as the Executive Chairman at Cypher Genomics, Inc. and as an Independent Director at Lineage Cell Therapeutics, Inc., MannKind Corp., and Asterias Biotherapeutics, Inc. Additionally, he was the Managing Director at Shipston Group Ltd. Nordhoff holds an MBA from The Trustees of Columbia University in The City of New York and an undergraduate degree from The Johns Hopkins University.

Henry Nordhoff active positions

CompaniesPositionStart
Chairman 2011-05-15
Chief Executive Officer -
Director/Board Member -
Chairman 2012-12-31

Former positions of Henry Nordhoff

CompaniesPositionEnd
ASTERIAS BIOTHERAPEUTICS INC Director/Board Member 2014-04-09
LINEAGE CELL THERAPEUTICS, INC. Director/Board Member 2014-04-06
Chief Executive Officer 2009-05-16
Chairman -
Private Equity Investor -
See the detail of Henry Nordhoff's experience

Training of Henry Nordhoff

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

65

1st degree connections

13

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies13

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Commercial Services

Consumer Services

Health Services

Distribution Services

Health Services

Health Technology

Finance

Technology Services

  1. Stock Market
  2. Insiders
  3. Henry Nordhoff